Submission Details
| 510(k) Number | K881345 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 30, 1988 |
| Decision Date | May 11, 1988 |
| Days to Decision | 42 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | — |
K881345 is an FDA 510(k) clearance for the IMX FERRITIN, a Igg, Ferritin, Antigen, Antiserum, Control (Class II — Special Controls, product code DGD), submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on May 11, 1988, 42 days after receiving the submission on March 30, 1988. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5510.
| 510(k) Number | K881345 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 30, 1988 |
| Decision Date | May 11, 1988 |
| Days to Decision | 42 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | — |
| Product Code | DGD — Igg, Ferritin, Antigen, Antiserum, Control |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5510 |